stage ii uterine corpus cancer
Showing 1 - 14 of 14
Lymphedema, Stage 0 Cervical Cancer, Stage 0 Uterine Corpus Cancer Trial in Philadelphia (Management of Therapy Complications,
Terminated
- Lymphedema
- +18 more
- Management of Therapy Complications
- Quality-of-Life Assessment
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jun 11, 2021
Endometrial Adenocarcinoma, Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer Trial in Bronx (drug, radiation,
Terminated
- Endometrial Adenocarcinoma
- +8 more
- Paclitaxel
- +4 more
-
Bronx, New YorkAlbert Einstein College of Medicine
Apr 21, 2021
Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer, Stage II Uterine Corpus Cancer Trial in Bronx (Exercise
Completed
- Stage IA Uterine Corpus Cancer
- +7 more
- Exercise Intervention
-
Bronx, New YorkAlbert Einstein College of Medicine
Sep 13, 2019
Complex Endometrial Hyperplasia With Atypia, Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer Trial in Cleveland
Completed
- Complex Endometrial Hyperplasia With Atypia
- +3 more
- Weight Loss Specialist
- +2 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Nov 15, 2018
Stage I Breast Cancer, Stage I Cervical Cancer, Stage I Ovarian Cancer Trial in Philadelphia, Reading (Informational
Completed
- Stage I Breast Cancer
- +38 more
- Informational Intervention
-
Philadelphia, Pennsylvania
- +1 more
Feb 20, 2018
Prognostic Biomarkers in Patients With Endometrial Cancer
Completed
- Endometrial Adenocarcinoma
- +5 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Aug 22, 2017
Lymphedema, Stage IA Cervical Cancer, Stage IA Uterine Corpus Cancer Trial in United States (Quality-of-Life Assessment,
Unknown status
- Lymphedema
- +13 more
- Quality-of-Life Assessment
- +5 more
-
Birmingham, Alabama
- +212 more
May 3, 2017
Collecting Tumor Samples From Patients With Gynecological Tumors
Completed
- Borderline Ovarian Clear Cell Tumor
- +85 more
- Laboratory Biomarker Analysis
-
Fayetteville, Arkansas
- +186 more
Oct 26, 2016
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Buffalo (biological, other, drug)
Completed
- Anaplastic Astrocytoma
- +64 more
- DEC-205/NY-ESO-1 Fusion Protein CDX-1401
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 3, 2016
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous
Completed
- Endometrial Adenocarcinoma
- +7 more
- Laboratory Biomarker Analysis
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Mar 17, 2016
Endometrial Adenocarcinoma, Stage I Uterine Corpus Cancer, Stage I Uterine Sarcoma Trial in Philadelphia (Laparoscopic Surgery,
Completed
- Endometrial Adenocarcinoma
- +4 more
- Laparoscopic Surgery
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
May 27, 2015
Response in Tissue Samples From Patients With Endometrial Cancer
Not yet recruiting
- Stage I Uterine Corpus Cancer
- +3 more
- Laboratory Biomarker Analysis
- Study of Socioeconomic and Demographic Variables
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
May 27, 2015
Biomarkers in Samples From Patients With Endometrial Cancer
Not yet recruiting
- Lynch Syndrome
- +5 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
May 27, 2015
Blood and Tissue Samples From Patients With Uterine Cancer
Not yet recruiting
- Endometrial Serous Adenocarcinoma
- +4 more
- Diagnostic Laboratory Biomarker Analysis
- +5 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
May 27, 2015